Mercer Global Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.2M | Buy |
231,520
+45,328
| +24% | +$3.97M | 0.03% | 331 |
|
|
2026
Q1 | $15.9M | Buy |
186,192
+13,122
| +8% | +$1.17M | 0.02% | 371 |
|
|
2025
Q4 | $16.1M | Buy |
173,070
+44,505
| +35% | +$3.49M | 0.02% | 378 |
|
|
2025
Q3 | $10.3M | Buy |
128,565
+5,116
| +4% | +$436K | 0.02% | 456 |
|
|
2025
Q2 | $11.2M | Sell |
123,449
-846
| -0.7% | -$77.2K | 0.02% | 362 |
|
|
2025
Q1 | $11.6M | Sell |
124,295
-8,522
| -6% | -$763K | 0.03% | 333 |
|
|
2024
Q4 | $12.1M | Buy |
132,817
+494
| +0.4% | +$47.1K | 0.03% | 321 |
|
|
2024
Q3 | $13.6M | Buy |
132,323
+5,564
| +4% | +$567K | 0.03% | 262 |
|
|
2024
Q2 | $8.88M | Buy |
126,759
+2,541
| +2% | +$234K | 0.02% | 328 |
|
|
2024
Q1 | $11.2M | Buy |
124,218
+45,080
| +57% | +$3.82M | 0.03% | 291 |
|
|
2023
Q4 | $6.31M | Sell |
79,138
-3,596
| -4% | -$270K | 0.02% | 409 |
|
|
2023
Q3 | $5.88M | Sell |
82,734
-5,095
| -6% | -$381K | 0.02% | 389 |
|
|
2023
Q2 | $6.77M | Sell |
87,829
-22,635
| -20% | -$1.75M | 0.03% | 373 |
|
|
2023
Q1 | $8.3M | Buy |
110,464
+33,677
| +44% | +$2.5M | 0.04% | 306 |
|
|
2022
Q4 | $6.05M | Buy |
76,787
+8,793
| +13% | +$659K | 0.03% | 378 |
|
|
2022
Q3 | $4.78M | Sell |
67,994
-3,082
| -4% | -$242K | 0.03% | 387 |
|
|
2022
Q2 | $5.7M | Sell |
71,076
-4,209
| -6% | -$329K | 0.03% | 332 |
|
|
2022
Q1 | $5.71M | Buy |
75,285
+1,545
| +2% | +$122K | 0.03% | 350 |
|
|
2021
Q4 | $6.29M | Sell |
73,740
-10,087
| -12% | -$788K | 0.04% | 318 |
|
|
2021
Q3 | $6.34M | Buy |
83,827
+10,696
| +15% | +$849K | 0.04% | 297 |
|
|
2021
Q2 | $5.95M | Buy |
73,131
+8,698
| +13% | +$711K | 0.05% | 292 |
|
|
2021
Q1 | $5.08M | Buy |
64,433
+2,439
| +4% | +$191K | 0.05% | 294 |
|
|
2020
Q4 | $5.3M | Buy |
61,994
+2,886
| +5% | +$239K | 0.07% | 220 |
|
|
2020
Q3 | $4.56M | Sell |
59,108
-11,014
| -16% | -$840K | 0.07% | 214 |
|
|
2020
Q2 | $5.14M | Buy |
70,122
+72
| +0.1% | +$5.11K | 0.09% | 167 |
|
|
2020
Q1 | $4.65M | Buy |
70,050
+7,420
| +12% | +$523K | 0.1% | 174 |
|
|
2019
Q4 | $4.31M | Buy |
62,630
+918
| +1% | +$62.6K | 0.09% | 197 |
|
|
2019
Q3 | $4.54M | Buy |
61,712
+3,959
| +7% | +$287K | 0.11% | 162 |
|
|
2019
Q2 | $4.14M | Buy |
57,753
+12,236
| +27% | +$869K | 0.11% | 156 |
|
|
2019
Q1 | $3.12M | Buy |
+45,517
| New | +$2.94M | 0.11% | 158 |
|
Other funds holding CL
Mercer Global Advisors's CL Position: Q2 2026 in Review
Mercer Global Advisors increased its Colgate-Palmolive (CL) stake by 24% in Q2 2026, buying an estimated $3.97M and bringing the position to 231,520 shares worth $21.2M. The position accounts for 0.03% of the portfolio, ranked #331.
Mercer Global Advisors first reported a position in CL in Q1 2019 and has held it in 30 quarters since. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Mercer Global Advisors held 231,520 shares of Colgate-Palmolive worth $21.2M as of Q2 2026.
- Mercer Global Advisors bought 45,328 Colgate-Palmolive shares in Q2 2026, an estimated $3.97M.
- Colgate-Palmolive made up 0.03% of Mercer Global Advisors's portfolio in Q2 2026, its #331 holding.
- Mercer Global Advisors first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 30 quarters since.
- 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.